The study by Arabzadeh et al. (2016) treated ovarian cancer cell line SKOV-3 with LTA, LPS, and recombinant human Il-6 alone or in combination with NF-kB inhibitor or STAT3 inhibitor. The gene discussed is IL6; the disease is ovarian carcinoma.